AR098693A1 - Método para producir células del epitelio pigmentario retiniano (rpe) - Google Patents
Método para producir células del epitelio pigmentario retiniano (rpe)Info
- Publication number
- AR098693A1 AR098693A1 ARP140104590A ARP140104590A AR098693A1 AR 098693 A1 AR098693 A1 AR 098693A1 AR P140104590 A ARP140104590 A AR P140104590A AR P140104590 A ARP140104590 A AR P140104590A AR 098693 A1 AR098693 A1 AR 098693A1
- Authority
- AR
- Argentina
- Prior art keywords
- cells
- rpe
- retinian
- epitel
- pigmentary
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Ophthalmology & Optometry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361914445P | 2013-12-11 | 2013-12-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR098693A1 true AR098693A1 (es) | 2016-06-08 |
Family
ID=52446403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP140104590A AR098693A1 (es) | 2013-12-11 | 2014-12-10 | Método para producir células del epitelio pigmentario retiniano (rpe) |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP3080248A1 (enExample) |
| JP (1) | JP2017504311A (enExample) |
| KR (1) | KR101871084B1 (enExample) |
| CN (1) | CN105814194A (enExample) |
| AR (1) | AR098693A1 (enExample) |
| AU (1) | AU2014363032A1 (enExample) |
| BR (1) | BR112016012129A8 (enExample) |
| CA (1) | CA2933083A1 (enExample) |
| HK (1) | HK1221734A1 (enExample) |
| IL (1) | IL245594A0 (enExample) |
| MX (1) | MX2016007671A (enExample) |
| TW (2) | TW201823451A (enExample) |
| WO (1) | WO2015087231A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3221318B1 (en) * | 2014-11-21 | 2021-08-25 | Rigel Pharmaceuticals, Inc. | Fused imidazole derivatives as tgf-beta inhibitors |
| MX2017008818A (es) * | 2014-12-30 | 2018-03-14 | Cell Cure Neurosciences Ltd | Metodos para tratar enfermedades de la retina. |
| EP3916085A1 (en) | 2014-12-30 | 2021-12-01 | Cell Cure Neurosciences Ltd. | Assessing retinal pigment epithelial cell populations |
| KR20170115514A (ko) * | 2014-12-30 | 2017-10-17 | 셀 큐어 뉴로사이언시스 리미티드 | Rpe 세포 집단 및 이를 생성하는 방법 |
| WO2017021973A1 (en) | 2015-08-05 | 2017-02-09 | Cell Cure Neurosciences Ltd. | Preparation of retinal pigment epithelium cells |
| EP4001402A1 (en) | 2015-09-08 | 2022-05-25 | FUJIFILM Cellular Dynamics, Inc. | Macs-based purification of stem cell-derived retinal pigment epithelium |
| AU2016321170B2 (en) | 2015-09-08 | 2022-09-01 | Fujifilm Cellular Dynamics | Method for reproducible differentiation of clinical-grade retinal pigment epithelium cells |
| ES2862676T3 (es) | 2015-10-20 | 2021-10-07 | Fujifilm Cellular Dynamics Inc | Producción de células precursoras hematopoyéticas multilinaje mediante programación genética |
| WO2017091844A1 (en) * | 2015-12-04 | 2017-06-08 | Bond University Ltd | Methods of differentiating retinal cells |
| CN106344932B (zh) * | 2016-08-26 | 2019-12-27 | 首都医科大学附属北京同仁医院 | 一种用于提高视网膜退行性疾病基因治疗效果的组合物及其应用 |
| FI3551216T3 (fi) | 2016-12-07 | 2024-10-14 | Mayo Found Medical Education & Res | Menetelmät ja materiaalit fibriinitukien käyttämiseksi verkkokalvon pigmenttiepiteelin siirroissa |
| CN106906178A (zh) * | 2017-04-07 | 2017-06-30 | 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 | 培养上皮细胞的组合物及其保持上皮样细胞形态中的应用 |
| AU2018254442B2 (en) | 2017-04-18 | 2024-03-28 | FUJIFILM Cellular Dynamics, Inc. | Antigen-specific immune effector cells |
| WO2018226648A1 (en) * | 2017-06-05 | 2018-12-13 | Mayo Foundation For Medical Education And Research | Methods and materials for culturing, proliferating, and differentiating stem cells |
| CN109957545A (zh) | 2017-12-26 | 2019-07-02 | 江苏艾尔康生物医药科技有限公司 | 一种消化rpe细胞的方法 |
| TW202012390A (zh) * | 2018-06-29 | 2020-04-01 | 日商日本歐愛特農業科技股份有限公司 | 新穎之經取代吡唑衍生物 |
| CN113811605B (zh) * | 2019-05-15 | 2024-09-27 | 诺和诺德股份有限公司 | 从人多能干细胞获得眼野祖细胞的方法 |
| JP7344421B2 (ja) * | 2019-07-19 | 2023-09-14 | 東京エレクトロン株式会社 | 細胞の分化状態の評価方法 |
| WO2021020282A1 (ja) | 2019-07-26 | 2021-02-04 | 学校法人埼玉医科大学 | Ａｌｋ２／ａｃｖｒ１の細胞外領域を認識する抗体 |
| CN113699097B (zh) * | 2021-09-08 | 2023-06-09 | 湖南光琇高新生命科技有限公司 | 视网膜色素上皮细胞的制备方法 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG49267A1 (en) | 1989-08-14 | 1998-05-18 | Photogenesis Inc | Surgical instrument and cell isolation and transplantation |
| US6045791A (en) | 1992-03-06 | 2000-04-04 | Photogenesis, Inc. | Retinal pigment epithelium transplantation |
| US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
| US5941250A (en) | 1996-11-21 | 1999-08-24 | University Of Louisville Research Foundation Inc. | Retinal tissue implantation method |
| WO2004033635A2 (en) | 2002-10-04 | 2004-04-22 | Tissuetech, Inc. | Retinal pigment epithelial cell cultures on amniotic membrane and transplantation |
| EP2929782A1 (en) | 2004-01-23 | 2015-10-14 | Ocata Therapeutics, Inc. | Improved modalities for the treatment of degenerative diseases of the retina |
| US7838727B2 (en) | 2004-11-04 | 2010-11-23 | Advanced Cell Technology, Inc. | Derivation of embryonic stem cells |
| US7893315B2 (en) | 2004-11-04 | 2011-02-22 | Advanced Cell Technology, Inc. | Derivation of embryonic stem cells and embryo-derived cells |
| US20090227032A1 (en) | 2005-12-13 | 2009-09-10 | Kyoto University | Nuclear reprogramming factor and induced pluripotent stem cells |
| US8278104B2 (en) | 2005-12-13 | 2012-10-02 | Kyoto University | Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2 |
| EP4223769A3 (en) | 2005-12-13 | 2023-11-01 | Kyoto University | Nuclear reprogramming factor |
| EP2128244A4 (en) | 2007-01-18 | 2012-05-09 | Riken | PROCESS FOR INDUCTION / DIFFERENTIATION TO A PHOTOREZEPTORZELLE |
| CN101743306A (zh) | 2007-03-23 | 2010-06-16 | 威斯康星校友研究基金会 | 体细胞重编程 |
| CN101688178B (zh) | 2007-04-18 | 2013-12-04 | 哈达锡特医学研究服务及发展有限公司 | 干细胞衍生的视网膜色素上皮细胞 |
| JP2008307007A (ja) | 2007-06-15 | 2008-12-25 | Bayer Schering Pharma Ag | 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞 |
| DK2209888T3 (da) | 2007-10-12 | 2020-01-20 | Astellas Inst For Regenerative Medicine | Forbedrede fremgangsmåder til fremstilling af rpe-celler og sammensætninger af rpe-celler |
| GB0806746D0 (en) | 2008-04-14 | 2008-05-14 | Ucl Business Plc | Membrane |
| CA3066806C (en) | 2009-08-24 | 2023-03-07 | David M. Gamm | Substantially pure human retinal progenitor, forebrain progenitor, and retinal pigment epithelium cell cultures and methods of making the same |
| WO2011063005A2 (en) | 2009-11-17 | 2011-05-26 | Advanced Cell Technology, Inc. | Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells |
| EP2383333B1 (en) | 2010-04-28 | 2015-05-27 | Technische Universität Dresden | Method for producing polarized retinal progenitor cells from pluripotent stem cells and their differentiation into retinal pigment epithelium cells |
| PL2577318T3 (pl) * | 2010-05-25 | 2019-12-31 | Memorial Sloan-Kettering Cancer Center | Sposób różnicowania ludzkich embrionalnych komórek macierzystych do nocyceptorów i ich zastosowania |
| GB201011313D0 (en) | 2010-07-05 | 2010-08-18 | Ucl Business Plc | Implantation devices, methods and implants |
| EP3549617B1 (en) | 2010-07-12 | 2023-09-13 | University of Southern California | Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same |
| US8871744B2 (en) | 2010-07-21 | 2014-10-28 | B & G Partyers, LLC | Compounds and methods for selectively targeting tumor-associated mucins |
| CN102465111A (zh) * | 2010-11-19 | 2012-05-23 | 薛志刚 | 一种体外人胚胎干细胞诱导分化为视网膜色素上皮细胞的试验方法 |
| US10390856B2 (en) | 2011-01-18 | 2019-08-27 | Minipumps, Llc | Surgical implantation instrument |
| WO2012177968A1 (en) | 2011-06-22 | 2012-12-27 | The Schepens Eye Research Institute, Inc. | A scaffold for subretinal cell transplantation and drug delivery |
| WO2013074681A1 (en) | 2011-11-14 | 2013-05-23 | Advanced Cell Technology, Inc. | Pharmaceutical preparations of human rpe cells and uses thereof |
| US9850463B2 (en) | 2012-02-01 | 2017-12-26 | The Regents Of The University Of California | Methods of culturing retinal pigmented epithelium cells, including xeno-free production, RPE enrichment, and cryopreservation |
| CN102618488A (zh) * | 2012-03-15 | 2012-08-01 | 中国人民解放军第三军医大学第一附属医院 | 一种制备视网膜色素上皮细胞的方法 |
| ES2688019T3 (es) | 2012-06-05 | 2018-10-30 | The Regents Of The University Of California | Métodos y composiciones para la producción acelerada de células epiteliales pigmentadas retinianas a partir de células pluripotentes |
| US20150368713A1 (en) | 2013-02-01 | 2015-12-24 | THE UNITED STATES OF AMERICAN, as represented by the Secretary, Department of Health and Human Serv | METHOD FOR GENERATING RETINAL PIGMENT EPITHELIUM (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCs) |
-
2014
- 2014-12-08 CN CN201480067617.3A patent/CN105814194A/zh active Pending
- 2014-12-08 AU AU2014363032A patent/AU2014363032A1/en not_active Abandoned
- 2014-12-08 WO PCT/IB2014/066703 patent/WO2015087231A1/en not_active Ceased
- 2014-12-08 CA CA2933083A patent/CA2933083A1/en not_active Abandoned
- 2014-12-08 EP EP14833537.5A patent/EP3080248A1/en not_active Withdrawn
- 2014-12-08 HK HK16109751.2A patent/HK1221734A1/zh unknown
- 2014-12-08 BR BR112016012129A patent/BR112016012129A8/pt not_active Application Discontinuation
- 2014-12-08 MX MX2016007671A patent/MX2016007671A/es unknown
- 2014-12-08 JP JP2016538000A patent/JP2017504311A/ja active Pending
- 2014-12-08 KR KR1020167018138A patent/KR101871084B1/ko not_active Expired - Fee Related
- 2014-12-09 TW TW106131045A patent/TW201823451A/zh unknown
- 2014-12-09 TW TW103142847A patent/TW201538726A/zh unknown
- 2014-12-10 AR ARP140104590A patent/AR098693A1/es unknown
-
2016
- 2016-05-10 IL IL245594A patent/IL245594A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112016012129A8 (pt) | 2020-05-12 |
| WO2015087231A1 (en) | 2015-06-18 |
| CN105814194A (zh) | 2016-07-27 |
| HK1221734A1 (zh) | 2017-06-09 |
| TW201823451A (zh) | 2018-07-01 |
| MX2016007671A (es) | 2016-10-14 |
| EP3080248A1 (en) | 2016-10-19 |
| BR112016012129A2 (pt) | 2017-08-08 |
| KR101871084B1 (ko) | 2018-06-25 |
| TW201538726A (zh) | 2015-10-16 |
| KR20160095118A (ko) | 2016-08-10 |
| CA2933083A1 (en) | 2015-06-18 |
| AU2014363032A1 (en) | 2016-06-09 |
| JP2017504311A (ja) | 2017-02-09 |
| IL245594A0 (en) | 2016-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR098693A1 (es) | Método para producir células del epitelio pigmentario retiniano (rpe) | |
| CY1124311T1 (el) | Παρεμποδιστες dna-pk | |
| DOP2020000050A (es) | Inhibidores de la ectonucleótido pirofosfatasa-fosfodiesterasa 1 (enpp-1) y usos de los mismos | |
| MX2019005402A (es) | Terapias de combinacion del inhibidor de arginasa. | |
| DOP2019000168A (es) | Compuestos de amino-triazolopiridina y su uso en el tratamiento del cáncer | |
| CO2017004525A2 (es) | Dihidropirrolopiridinas inhibidoras de ror-gamma | |
| CR20190063A (es) | 3-metil pirazinas 2,5-disustituídas y 3-metil pirazinas 2,5,6-trisustituídas como inhibidores alostéricos de shp2 | |
| MX2020008024A (es) | Compuestos de indol carboxamida útiles como inhibidores de cinasas. | |
| MX2017016655A (es) | Formulaciones oftalmicas de inhibidores de tirosina quinasa, metodos de uso de las mismas y metodos de preparacion de las mismas. | |
| BR112017024384A2 (pt) | bactérias modificadas para reduzir hiperfenilalaninemia | |
| MX370018B (es) | Metodos mejorados para la elaboracion de terapias celulares adoptivas. | |
| MX389847B (es) | Composiciones de ésteres de ácido cannabidiólico y usos de las mismas. | |
| NZ728072A (en) | Modulators of toll-like receptors for the treatment of hiv | |
| CL2016000060A1 (es) | Derivados piperidinil indol y su uso como inhibidores factor de complemento b. | |
| PE20150223A1 (es) | Anticuerpos antagonistas mejorados contra factor-8 de crecimiento y diferenciacion y usos de los mismos | |
| CU20140072A7 (es) | Derivados de dihidro-oxazina y dihidro-pirido-oxazina | |
| ECSP17013903A (es) | Protein kinase c inhibitors and methods of their use | |
| MX2014005342A (es) | Inhibidores del virus de la hepatitis c. | |
| ECSP14030779A (es) | Inhibidores del nampt | |
| MX2019009783A (es) | Metodo para fabricar una barra que comprende antitranspirante. | |
| MX2018002318A (es) | Proceso mejorado para producir fucoxantina y/o polisacaridos de microalgas. | |
| CL2017001301A1 (es) | Composiciones oftálmicas estabilizadas de omega 3 | |
| MX2017005861A (es) | Metodos para el control transcripcional objetivo en regiones del super mejorador. | |
| EA201891440A1 (ru) | Составы/композиции, содержащие ингибитор btk | |
| EA201891664A1 (ru) | Составы/композиции, содержащие ингибитор btk |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |